Trial · NCT02536755
Results by group576
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 576
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Unrestricted mobility: Study Baseline | 31 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Walks with difficulty: Study Baseline | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Walks with orthopedic aid: Study Baseline | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Requires wheelchair: Study Baseline | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Bedridden: Study Baseline | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Unrestricted mobility: Week 52 | 31 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Walks with difficulty: Week 52 | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Walks with orthopedic aid: Week 52 | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Requires wheelchair: Week 52 | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Bedridden: Week 52 | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Unrestricted mobility: Week 104 | 28 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Walks with Difficulty: Week 104 | 1 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Walks with orthopedic aid: Week 104 | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Requires wheelchair: Week 104 | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Bedridden: Week 104 | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Unrestricted mobility: Week 156 | 29 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Walks with difficulty: Week 156 | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Walks with orthopedic aid: Week 156 | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Requires wheelchair: Week 156 | 0 | Participants | |
| Number of Participants With Mobility Status Assessments at Study Baseline, Weeks 52, 104, 156 and 208 | Eliglustat | Bedridden: Week 156 | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02536755/results